Literature DB >> 12150156

Leukoencephalopathy and papovavirus infection after treatment with chemotherapy and anti-CD20 monoclonal antibody.

Paola Matteucci, Michele Magni, Massimo Di Nicola, Carmelo Carlo-Stella, Caterina Uberti, Alessandro M Gianni.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12150156     DOI： 10.1182/blood-2002-04-1271

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  14 in total

Review 1.  Does rituximab increase the incidence of infectious complications? A narrative review.

Authors:  Theodoros Kelesidis; George Daikos; Dimitrios Boumpas; Sotirios Tsiodras
Journal:  Int J Infect Dis       Date:  2010-11-11       Impact factor: 3.623

2.  Persistent B-cell depletion after rituximab for thrombocytopenic purpura.

Authors:  Gianni Bisogno
Journal:  Eur J Pediatr       Date:  2006-08-03       Impact factor: 3.183

3.  Lymphotropic polyomavirus and progressive multifocal leukoencephalopathy.

Authors:  Daniele Focosi; Richard Eric Kast; Fabrizio Maggi; Luca Ceccherini-Nelli; Mario Petrini
Journal:  J Clin Microbiol       Date:  2009-01       Impact factor: 5.948

Review 4.  Natalizumab and progressive multifocal leucoencephalopathy.

Authors:  J R Berger
Journal:  Ann Rheum Dis       Date:  2006-11       Impact factor: 19.103

5.  Infratentorial progressive multifocal leukoencephalopathy in a patient treated with fludarabine and rituximab.

Authors:  Simona Bonavita; Renata Conforti; Antonio Russo; Rosaria Sacco; Alessandro Tessitore; Antonio Gallo; Marida Della Corte; Maria Rosaria Monsurrò; Gioacchino Tedeschi
Journal:  Neurol Sci       Date:  2008-04-01       Impact factor: 3.307

Review 6.  Targeted B-cell depletion therapy in childhood-onset systemic lupus erythematosus: progress to date.

Authors:  Stephen D Marks; Kjell Tullus
Journal:  Paediatr Drugs       Date:  2007       Impact factor: 3.022

Review 7.  Risk of infection in patients with lymphoma receiving rituximab: systematic review and meta-analysis.

Authors:  Simone Lanini; Aoife C Molloy; Paul E Fine; Archibald G Prentice; Giuseppe Ippolito; Christopher C Kibbler
Journal:  BMC Med       Date:  2011-04-12       Impact factor: 8.775

8.  Rituximab in two cases of Goodpasture's syndrome.

Authors:  Birgit Schless; Suzan Yildirim; Daniel Beha; Frieder Keller; David Czock
Journal:  NDT Plus       Date:  2009-02-18

9.  Rituximab in the treatment of non-Hodgkin's lymphoma.

Authors:  Beate Hauptrock; Georg Hess
Journal:  Biologics       Date:  2008-12

10.  Biological therapies for the treatment of juvenile idiopathic arthritis: Lessons from the adult and pediatric experiences.

Authors:  Matthew L Stoll; Alisa C Gotte
Journal:  Biologics       Date:  2008-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.